In summary, it may be inferred that TRIM26 suppresses the proliferation, migration, and invasion of ccRCC cells by causing the degradation of ETK, resulting in the deactivation of AKT/mTOR signaling. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.